- Home
- AIRT vs FORA Comparison
AIRT vs FORA Comparison
Compare AIRT & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRT | FORA |
|---|---|---|
| Founded | 1980 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.1M | 66.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | AIRT | FORA |
|---|---|---|
| Price | $21.00 | $2.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.6K | ★ 16.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,153,263.00 |
| Revenue This Year | N/A | $51.82 |
| Revenue Next Year | N/A | $7.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.56 | $1.64 |
| 52 Week High | $26.70 | $2.71 |
Technical Indicators
Market Signals| Indicator | AIRT | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 39.79 | 46.06 |
| Support Level | $18.38 | $2.05 |
| Resistance Level | $24.74 | $2.12 |
| Average True Range (ATR) | 0.50 | 0.02 |
| MACD | -0.32 | 0.00 |
| Stochastic Oscillator | 18.79 | 40.00 |
Price Performance
Historical ComparisonAbout AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.